HilleVax, Inc. (HLVX)
NASDAQ: HLVX · IEX Real-Time Price · USD
12.30
+0.44 (3.71%)
Apr 19, 2024, 4:00 PM EDT - Market closed
HilleVax Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for HilleVax stock have an average target of 28.5, with a low estimate of 22 and a high estimate of 34. The average target predicts an increase of 131.71% from the current stock price of 12.30.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 21, 2024.
Analyst Ratings
The average analyst rating for HilleVax stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +127.64% | Mar 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $28 | Strong Buy | Initiates | $28 | +127.64% | Dec 13, 2023 |
| Guggenheim | Guggenheim | Strong Buy Maintains $38 → $34 | Strong Buy | Maintains | $38 → $34 | +176.42% | Nov 15, 2023 |
| Stifel | Stifel | Strong Buy Maintains $35 → $30 | Strong Buy | Maintains | $35 → $30 | +143.90% | Nov 10, 2023 |
| JP Morgan | JP Morgan | Buy Maintains $23 → $22 | Buy | Maintains | $23 → $22 | +78.86% | May 16, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.08
from -3.04
EPS Next Year
-3.59
from -3.08
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 13.1M | 268.5M | 554.8M |
| Avg | n/a | n/a | 3.2M | 151.0M | 313.5M |
| Low | n/a | n/a | n/a | n/a | 43.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 8,321.9% | 267.4% |
| Avg | - | - | - | 4,637.1% | 107.6% |
| Low | - | - | - | - | -71.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.75 | -2.97 | -2.88 | 0.16 | 0.90 |
| Avg | -3.08 | -3.59 | -4.07 | -2.16 | -0.72 |
| Low | -3.33 | -3.93 | -4.49 | -3.84 | -1.85 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.